[Effect of demineralized bone matrix modified by laminin α4 chain functional peptide on H-type angiogenesis and osteogenesis to promote bone defect repair]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020 Dec 15;34(12):1594-1601. doi: 10.7507/1002-1892.202006081.
[Article in Chinese]

Abstract

Objective: Based on the cell-extracellular matrix adhesion theory in selective cell retention (SCR) technology, demineralized bone matrix (DBM) modified by simplified polypeptide surface was designed to promote both bone regeneration and angiogenesis.

Methods: Functional peptide of α4 chains of laminin protein (LNα4), cyclic RGDfK (cRGD), and collagen-binding domain (CBD) peptides were selected. CBD-LNα4-cRGD peptide was synthesized in solid phase and modified on DBM to construct DBM/CBD-LNα4-cRGD scaffold (DBM/LN). Firstly, scanning electron microscope and laser scanning confocal microscope were used to examine the characteristics and stability of the modified scaffold. Then, the adhesion, proliferation, and tube formation properties of CBD-LNα4-cRGD peptide on endothelial progenitor cells (EPCs) were detected, respectively. Western blot method was used to verify the molecular mechanism affecting EPCs. Finally, 24 10-week-old male C57 mice were used to establish a 2-mm-length defect of femoral bone model. DBM/LN and DBM scaffolds after SCR treatment were used to repair bone defects in DBM/LN group ( n=12) and DBM group ( n=12), respectively. At 8 weeks after operation, the angiogenesis and bone regeneration ability of DBM/LN scaffolds were evaluated by X-ray film, Micro-CT, angiography, histology, and immunofluorescence staining [CD31, endomucin (Emcn), Ki67].

Results: Material related tests showed that the surface of DBM/LN scaffold was rougher than DBM scaffold, but the pore diameter did not change significantly ( t=0.218, P=0.835). After SCR treatment, DBM/LN scaffold was still stable and effective. Compared with DBM scaffold, DBM/LN scaffold could adhere to more EPCs after the surface modification of CBD-LNα4-cRGD ( P<0.05), and the proliferation rate and tube formation ability increased. Western blot analysis showed that the relative expressions of VEGF, phosphorylated FAK (p-FAK), and phosphorylated ERK1/2 (p-ERK1/2) proteins were higher in DBM/LN than in DBM ( P<0.05). In the femoral bone defect model of mice, it was found that mice implanted with DBM/LN scaffold had stronger angiogenesis and bone regeneration capacity ( P<0.05), and the number of CD31 hiEmcn hi cells increased significantly ( P<0.05).

Conclusion: DBM/LN scaffold can promote the adhesion of EPCs. Importantly, it can significantly promote the generation of H-type vessels and realize the effective coupling between angiogenesis and bone regeneration in bone defect repair.

目的: 基于选择性细胞滞留(selective cell retention,SCR)技术中的细胞与细胞外基质黏附理论,拟设计一种简化多肽表面修饰脱钙骨基质(demineralized bone matrix,DBM),以期能同时促进骨再生与血管生成。.

方法: 选择层粘连蛋白(laminin,LN)α4 链核心区域功能肽(LNα4)、环状 RGD(cyclic RGDfK,cRGD)和带胶原结构域肽(collagen-binding domain,CBD),固相合成 CBD-LNα4-cRGD 多肽,表面修饰于 DBM,构建 DBM/CBD-LNα4-cRGD(以下简称 DBM/LN)支架材料。观测 DBM/LN 形态特征、CBD-LNα4-cRGD 表面修饰 DBM 的稳定性以及 CBD-LNα4-cRGD 表面修饰对小鼠血管内皮祖细胞(endothelial progenitor cells,EPCs)黏附、增殖以及管腔形成的影响,Western blot 验证其影响 EPCs 血管生成的分子机制。然后,取 24 只 10 周龄雄性 C57 小鼠制备 2 mm 长股骨缺损模型,分别采用经 SCR 技术处理的 DBM/LN(DBM/LN 组 , n=12)和 DBM(DBM 组, n=12)修复骨缺损。术后 8 周,行影像学检查、血管造影、组织学及免疫荧光染色[CD31、内皮黏蛋白(endomucin,Emcn)、Ki67]观察,评估 DBM/LN 促进血管生成和骨再生能力。.

结果: 材料相关检测显示,与 DBM 相比,DBM/LN 表面更粗糙,但孔径差异无统计学意义( t=0.218, P=0.835);经 SCR 技术处理后,荧光强度提示 DBM/LN 支架稳定有效;与 DBM 相比,CBD-LNα4-cRGD 表面修饰后,DBM/LN 能黏附更多的 EPCs ( P<0.05),且增殖速度增加、管腔形成能力增强。Western blot 检测示 DBM/LN 中 EPCs 表达 VEGF、p-FAK 和 p-ERK1/2 水平显著高于 DBM( P<0.05)。动物实验观测显示,与 DBM 组相比,DBM/LN 组骨缺损处血管生成和骨再生能力更强,血管体积和血管表面积差异均有统计学意义( P<0.05),CD31 hiEmcn hi细胞数量显著增加( P<0.05)。.

结论: DBM/LN 支架材料能促进 EPCs 黏附、H 型血管生成,实现小鼠骨缺损修复中血管生成和骨再生的有效耦联。.

Keywords: H-type vessels; Laminin α4 chains; bone regeneration; demineralized bone matrix; endothelial progenitor cells; mouse.

MeSH terms

  • Animals
  • Bone Matrix*
  • Bone Regeneration
  • Laminin
  • Male
  • Mice
  • Osteogenesis*
  • Peptides
  • Tissue Scaffolds

Substances

  • Laminin
  • Peptides

Grants and funding

国家自然科学基金面上项目(81472059、81974336)